Skip to main content
. Author manuscript; available in PMC: 2019 Apr 9.
Published in final edited form as: Vaccine. 2017 Aug 1;35(37):4942–4951. doi: 10.1016/j.vaccine.2017.07.086

Fig. 6.

Fig. 6.

Multi-RG1 epitope fusions elicit broadly protection against skin challenge with HPV quazivirions. Groups of 4 rabbits were immunized four times with 125 µg of Fla69, Fla32, Fla65, or Fla76 or placebo (Pla) on days 0, 21, 42 and 63. On day 91 the rabbits were challenged on the skin with quazivirus of HPV types 6, 16, 18, 31, 58 as well as CRPV. Graphs show wart volume readings 8 weeks post-challenge.